Showing 1 - 3 results of 3 for search 'Mohammed M Milhem', query time: 0.02s Refine Results
  1. 1
    Pembrolizumab plus Pharmacologic Ascorbate in the Treatment of Leiomyosarcoma

    Pembrolizumab plus Pharmacologic Ascorbate in the Treatment of Leiomyosarcoma by John M. Rieth, Alex C. Belzer, Mackenzie L. Walhof, Mohammed M. Milhem

    Published 2024-08-01
    Get full text
    Article
  2. 2
    Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II trial

    Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II tria... by Celeste Lebbe, Parminder Singh, Omid Hamid, Frances A Collichio, Igor Puzanov, Merrick Ross, Theodore Logan, Philip Friedlander, Claus Garbe, Janice M Mehnert, John Glaspy, Axel Hauschild, Wendy Snyder, Jason A Chesney, Mohammed M Milhem, Harshada Joshi

    Published 2023-05-01
    Get full text
    Article
  3. 3
    A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative analyses

    A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative anal... by Howard Streicher, Sandra P D'Angelo, Gary K Schwartz, Suzanne George, James L Chen, Cristina R Antonescu, Allison L Richards, Mohammed M Milhem, Nathan D Seligson, Austin C Goodrich, Brian A Van Tine, Jordan D Campbell, David A Liebner, William D Tap

    Published 2024-09-01
    Get full text
    Article

Search Tools: